Wet wipes designed for healthcare settings occupy a uniquely complex position in the regulatory landscape. Unlike a moisturising face wipe or a household cleaning cloth, a wipe used to disinfect a surgical site or cleanse a wound can fall under entirely different legal frameworks depending on its intended purpose and active ingredients. For companies looking to outsource the production of healthcare wet wipes, understanding this regulatory complexity before selecting a manufacturing partner is not just advisable — it is essential to a sound outsourcing strategy.
Getting the classification right from the start shapes everything downstream: the testing protocols required, the certifications your manufacturer must hold, the documentation you need to bring a product to market, and ultimately the speed at which you can scale. If you are evaluating partners for contract manufacturing of wet wipes, exploring the full scope of what a specialist can offer is a practical first step. Our healthcare and hygiene product services cover the full production chain, from formulation to final packaging.
The three regulatory categories that define wet wipes
Healthcare wet wipes do not belong to a single regulatory category. Depending on their intended use, formulation, and the claims made on the label, a wet wipe can be classified as a cosmetic product, a biocidal product, or a medical device. Each classification carries its own legal definition, and the boundaries between them are not always obvious.
Understanding the distinctions between these three categories is the foundation of any compliant product development process. Here is how each category applies to wet wipes in practice:
- Cosmetic wet wipes are products intended to cleanse, perfume, or protect the skin without a pharmacological or physiological effect. Examples include everyday facial cleansing wipes, baby wipes, and general personal hygiene wipes. These are regulated under cosmetics legislation and require a Cosmetic Product Safety Report, a Product Information File, and compliance with ingredient restrictions.
- Biocidal wet wipes contain active substances that destroy, deter, or neutralise harmful organisms. Disinfection wipes for skin or surfaces fall into this category when the primary function is antimicrobial action. In Europe, these are governed by the Biocidal Products Regulation (BPR), which requires active substance approval and, in many cases, product authorisation before market placement.
- Medical device wet wipes are those intended to achieve a medical purpose — such as wound cleansing, infection control in clinical settings, or use on compromised skin. Under the EU Medical Device Regulation (MDR), these products must meet General Safety and Performance Requirements, undergo clinical evaluation, and be covered by a comprehensive technical file.
It is also worth noting that some products sit at the boundary between categories. A wipe that both cleanses and disinfects, for example, may need to be assessed carefully to determine which regulation takes precedence. This is an area where early expert input saves considerable time and cost later in the development process.
How classification changes your compliance obligations
Once the regulatory category of a healthcare wet wipe is established, the compliance obligations that follow are significantly different in scope and complexity. The classification is not just a labelling decision — it determines the entire regulatory pathway a product must travel before it can reach the market.
For wet wipes compliance, the practical differences between categories are substantial. The table below gives a structured overview of the key obligations associated with each classification:
- Cosmetic products: Cosmetic Product Safety Report, Product Information File, ingredient notification, responsible person designation, and compliance with the Cosmetics Regulation (EC) No 1223/2009.
- Biocidal products: Active substance authorisation under BPR, product authorisation or simplified authorisation procedure, efficacy data, toxicological and ecotoxicological dossiers, and labelling requirements under the biocidal product framework.
- Medical devices (MDR): Risk management file aligned with ISO 14971, clinical evaluation report, technical file, conformity assessment procedure (which may involve a Notified Body depending on the device class), post-market surveillance, and UDI registration.
The MDR pathway in particular demands rigorous process quality throughout the entire supply chain. Manufacturers must operate under a certified quality management system — specifically ISO 13485 — and every step from product development to production and post-market follow-up must be documented and auditable. For companies outsourcing medical device wet wipes, this means the contract manufacturer’s quality systems become part of your own compliance posture.
Biocidal products regulation adds another layer of complexity because the approval of active substances is centralised at the EU level, while product authorisations are often handled nationally. This can affect timelines significantly, particularly when launching across multiple markets simultaneously. Knowing which classification applies — and planning the regulatory pathway accordingly — is one of the most consequential decisions in the early stages of product development.
What classification means for choosing a contract manufacturer
The regulatory category of your wet wipe directly determines the capabilities your contract manufacturer must have. Not every manufacturer is equipped to handle all three categories, and choosing a partner whose certifications and processes do not align with your product’s classification creates compliance gaps that are difficult and expensive to resolve after production has begun.
When evaluating a contract manufacturer for healthcare wet wipes, the following criteria should be assessed in relation to your specific classification:
For cosmetic wet wipes
- Compliance with ISO 22716 (Good Manufacturing Practice for cosmetics)
- Experience with cosmetic safety assessments and ingredient dossiers
- Capability to support Cosmos or Nordic Ecolabel certification if sustainability claims are relevant to your brand
For biocidal wet wipes
- Familiarity with BPR requirements and active substance documentation
- Ability to support efficacy testing and toxicological data compilation
- Experience navigating national product authorisation processes across target markets
For medical device wet wipes
- ISO 13485 certification covering the full scope of manufacturing activities
- MDR expertise including risk management under ISO 14971, clinical evaluation support, and technical file compilation
- Validated processes for pilot production, shelf-life testing, and change control management
A manufacturer capable of handling all three categories offers a particular advantage for companies with a diverse or evolving product portfolio. It removes the need to manage multiple supplier relationships for different product lines and ensures consistency in quality standards and communication across the board. We work across all three regulatory categories and hold ISO 9001, ISO 13485, ISO 14001, and ISO 22716 certifications, giving our partners a single point of accountability regardless of product classification.
Classification risk and how to manage it in your outsourcing model
Misclassification is one of the most consequential risks in wet wipe product development. A product placed on the market under the wrong regulatory framework can face withdrawal, enforcement action, or the need for a complete re-registration process — all of which carry significant cost and reputational consequences. Managing this risk requires deliberate steps both before and during the outsourcing relationship.
Classification risk is not static. A product’s regulatory status can change if its formulation is updated, if the intended use expands, or if new guidance from regulatory authorities redefines the boundaries between categories. This means classification should be reviewed at key milestones throughout the product lifecycle, not treated as a one-time determination at launch.
Practical steps to manage classification risk within your outsourcing model include:
- Conduct a classification assessment early. Before any formulation work begins, define the intended purpose of the product clearly and assess which regulatory framework applies. Where there is genuine ambiguity, seek a formal opinion or consult with a regulatory specialist.
- Align your contract manufacturer’s scope with your classification. Ensure that the manufacturing agreement explicitly covers the compliance activities associated with your product’s category, including which party is responsible for regulatory documentation, testing, and post-market obligations.
- Build classification review into change control processes. Any change to the formulation, intended use, or labelling claims should trigger a reassessment of regulatory classification. A well-structured contract manufacturing partnership includes change control procedures that flag these triggers automatically.
- Leverage your manufacturer’s regulatory expertise. A capable contract manufacturer should be able to support not just production, but also regulatory assistance — including reviewing documentation requirements, supporting technical file preparation, and advising on compliance when entering new markets.
- Maintain transparent communication throughout the product lifecycle. Regular updates and clear communication channels between your team and your manufacturing partner reduce the risk of compliance gaps developing unnoticed over time.
The regulatory landscape for healthcare wet wipes will continue to evolve, and companies that build classification awareness into their outsourcing model from the outset are far better positioned to adapt. Choosing a manufacturing partner with genuine regulatory depth — one that can support you from initial classification through to post-market surveillance — transforms compliance from a risk factor into a competitive advantage. If you are ready to explore what a structured, compliant manufacturing partnership looks like in practice, reach out to our team and we will work through the specifics with you. You can also discover our full range of healthcare and hygiene product capabilities to see how we support partners at every stage of the production chain.